Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP6V0D1 divergent transcript (ATP6V0D1-DT)
- Target
- ATP6V0D1-DT
- Molecular classification
- Long non-coding RNA (lncRNA)
01
Overview
ATP6V0D1 divergent transcript (ATP6V0D1-DT) is a long non-coding RNA gene, situated divergently within close proximity to the ATP6V0D1 protein-coding gene. Divergent transcripts are typically non-coding and may participate in regulation of neighboring gene expression, but specific molecular function, disease association, or pharmacological relevance for ATP6V0D1-DT has not been reported in established gene databases or functional studies[3][4][5].
- Other names
- ATP6V0D1-DTATP6V0D1 divergent transcript
02
Mechanism of action
Not applicable, as there are no drugs targeting this RNA
Beyond the preview
Go deeper on ATP6V0D1 divergent transcript (ATP6V0D1-DT).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ATP6V0D1 divergent transcript (ATP6V0D1-DT).